Insider · CIK 0001562645

Yanai Shlomo

Reports to the SEC for 9 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001562645

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	320,804
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-06	PMPhilip Morris International Inc.A Award	Director	AAward	+1,119 sh	$169.93	+$190K	10,120
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2025-05-07	PMPhilip Morris International Inc.A Award	Director	AAward	+1,002 sh	$174.82	+$175K	8,759
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	285,985
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	245,727
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-08	PMPhilip Morris International Inc.A Award	Director	AAward	+1,789 sh	$97.84	+$175K	7,501
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	169,274
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2023-05-03	PMPhilip Morris International Inc.A Award	Director	AAward	+1,812 sh	$96.58	+$175K	5,506
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	89,146
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2022-05-04	PMPhilip Morris International Inc.A Award	Director	AAward	+1,759 sh	$99.53	+$175K	3,598
2021-09-22	W R GRACE & COD Disposition to Issuer	Director	DDisposition to Issuer	−6,973 sh	—	—	0
2021-05-11	W R GRACE & COA Award	Director	AAward	+1,683 sh	—	—	6,973
2021-05-06	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+46.2K sh	—	—	53,740
2021-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−46.2K sh	—	—	0
2021-05-05	PMPhilip Morris International Inc.A Award	Director	AAward	+1,839 sh	$95.17	+$175K	1,839
2021-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+35.4K sh	—	—	35,406
2020-12-15	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,522 sh	—	—	7,522
2020-12-15	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,522 sh	—	—	0
2020-05-12	W R GRACE & COA Award	Director	AAward	+2,280 sh	—	—	5,290
2020-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+46.2K sh	—	—	46,218
2019-12-14	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	Director	AAward	+28.5K sh	—	—	28,506
2019-12-14	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+7,522 sh	—	—	7,522
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+6,371 sh	$12.90	+$82.2K	21,857
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+3,863 sh	$21.70	+$83.8K	25,720
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,140 sh	$41.23	+$88.2K	27,860
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+1,613 sh	$45.12	+$72.8K	29,473
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+1,577 sh	$58.98	+$93K	31,050
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+1,980 sh	$53.70	+$106K	33,030
2019-12-04	CAMBREX CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,766 sh	$40.06	+$111K	35,796
2019-12-04	CAMBREX CORPS Sale	Director	SSale	−35.8K sh	$60.00	−$2.15M	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+6,371 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+3,863 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+2,140 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,613 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,577 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+1,980 sh	—	—	0
2019-12-04	CAMBREX CORPStock Option (right to buyM Exercise/Conversion	Director	MExercise/Conversion	+2,766 sh	—	—	0
2019-06-20	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+126K sh	$3.00	+$378K	126,050
2019-05-08	W R GRACE & COA Award	Director	AAward	+1,532 sh	—	—	3,010
2019-04-24	CAMBREX CORPA Award	Director	AAward	+2,247 sh	—	—	15,486

Recent filings

Accepted (ET)
May 84
Yanai Shlomo0001628280-26-032904
SEC(opens sec.gov)
May 84
Yanai Shlomo0001628280-26-032727
SEC(opens sec.gov)
May 94
Yanai Shlomo0001413329-25-000115
SEC(opens sec.gov)
May 84
Yanai Shlomo0001628280-25-024000
SEC(opens sec.gov)
May 144
Yanai Shlomo0001628280-24-023244
SEC(opens sec.gov)
May 104
Yanai Shlomo0001413329-24-000120
SEC(opens sec.gov)
May 64
Yanai Shlomo0001628280-24-020746
SEC(opens sec.gov)
May 114
Yanai Shlomo0001209191-23-028732
SEC(opens sec.gov)
May 54
Yanai Shlomo0001413329-23-000145
SEC(opens sec.gov)
May 104
Yanai Shlomo0001209191-22-028165
SEC(opens sec.gov)
May 64
Yanai Shlomo0001182489-22-000037
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807